Dear Reader,

AI is giving a big boost to researchers developing and testing new drugs to treat diseases.

We invite you to join us for a webinar led by our tech editor, Eric Smalley, to better understand the role of AI in biomedical research and drug development.

This webinar will help you learn the different stages of developing drugs, from understanding how key proteins work through to clinical trials of new drugs, and how AI is playing a role at each step.

Experts will discuss how the technology works, how it's helping researchers find the best ways to attack diseases, how it's helping biotech and drug companies discover new therapies, and how it's helping pharmaceutical companies test the safety and effectiveness of new drugs in people. They will also discuss AI's limitations and help you set reasonable expectations.

• What: AI: accelerating biomedical research and drug development

• When: December 10, 2025, 11:00 a.m. Pacific/2:00 p.m. Eastern

• Where: Zoom. Please sign up here

• Who:

  • Jeffrey Skolnick, Regents' Professor of Computational Systems Biology, Georgia Institute of Technology

  • Benjamin P. Brown, Assistant Professor of Pharmacology and Center for AI in Protein Dynamics, Vanderbilt University

  • Eric Smalley, Science and Technology Editor, The Conversation U.S.